PBMs

Will PBMs Be the Next Target of Opioid Lawsuits?Experts weigh in on a recent lawsuit against PBMs, whether similar lawsuits will crop up, and the likely outcomes.
Walgreens-AmerisourceBergen Deal: 3 TakeawaysRetail drug chain giant Walgreens made a takeover approach to drug distributor AmerisourceBergen. Here’s what industry watchers want you to know about it.
The New Goal for PBMs: Transparency
The New Goal for PBMs: TransparencyTraditional pharmacy benefit managers (PBMs) have come under fire for what some critics say is a lack of transparency. Opaqueness may be on the way out.
Controversy heats up over pharmacy benefit manager DIR feesPBMs make the argument for DIR fees after a litany of complaints from industry stakeholders.
Top solutions to lower drug pricesPBMs partnering with pharmacies and drug makers may have a solution to nonadherence due to high pharma costs.
Groups praise lawsuit against Walgreens, CVSPharmacy and medical organizations lauded a new class action lawsuit against CVS Health and Walgreens, alleging the two pharmacy chains colluded with pharmacy benefit managers (PBMs) to drive up the cost of generic drugs.
Opinion: Top 2 takeaways from UBS Global Healthcare ConferenceThe conference raised important points about unregulated growth opportunities and new pharmacy arena players.
Four ways PBMs must change to thrive in the future
Four ways PBMs must change to thrive in the futureThe days of the traditional, channel-focused and largely enshrouded PBM business model have come and gone. Here’s what’s next.
Can Amazon change the pharmacy landscape?Industry experts analyze issues of mail delivery and transparency in the prescription drug market.
Why This PBM Comparison Is a Bit of a WhopperAre pharmacies really comparable to fast-food outlets?